In vivo anti-LAP monoclonal antibody enhances IL-17/IFN-γ responses and abrogates anti-CD3 induced oral tolerance. da Cunha AP, Wu HY, Rezende RM, Vandeventer T, Weiner HL Int Immunol. 2014 Sep 6. PMID: 25194146. Abstract CommentRecommendBookmarkWatch